ConductScience.org, home

Paper17533392

Melanoma incidence and mortality in Scotland 1979-2003.

MacKie RM and 7 others. Br J Cancer, 2007. Cited by 97 papers, by iCite.

Cite this record

ConductScience Library. Melanoma incidence and mortality in Scotland 1979-2003. Papers, record 17533392. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17533392

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Melanoma incidence and mortality in Scotland 1979-2003.
PubMed
Journal
Br J Cancer
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
97
iCite
Relative citation ratio, by iCite
2.57
iCite
Revised in PubMed
2023-11-05
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1MacKie RMR M
2Bray CC
3Vestey JJ
4Doherty VV
5Evans AA
6Thomson DD
7Nicolson MM
8Scottish Melanoma GroupGroup

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Skin NeoplasmsMajor topic
Adult
Age Factors
Aged
Aged, 80 and over
Female
Humans
Incidence
Male
Middle Aged
Scotland
Sex Characteristics
Survival Analysis
Time Factors
Tumor Burden

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116832794What motivates men age > or =50 years to participate in a screening program for melanoma?Cancer2006https://conductscience.org/library/papers/16832794PubMed
215967921Early detection of thick melanomas in the United States: beware of the nodular subtype.Arch Dermatol2005https://conductscience.org/library/papers/15967921PubMed
312241928Incidence of and survival from malignant melanoma in Scotland: an epidemiological study.Lancet2002https://conductscience.org/library/papers/12241928PubMed
412237925Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program.Cancer2002https://conductscience.org/library/papers/12237925PubMed
52864579Malignant melanoma in Scotland 1979-1983.Lancet1985https://conductscience.org/library/papers/2864579PubMed
611333289Recent trends in cutaneous melanoma incidence among whites in the United States.J Natl Cancer Inst2001https://conductscience.org/library/papers/11333289PubMed
715305162Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off?Melanoma Res2004https://conductscience.org/library/papers/15305162PubMed
812925966Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.Int J Cancer2003https://conductscience.org/library/papers/12925966PubMed
99486776Non-metastasizing melanoma?J Surg Oncol1998https://conductscience.org/library/papers/9486776PubMed
1016633005Gender-related differences in outcome for melanoma patients.Ann Surg2006https://conductscience.org/library/papers/16633005PubMed
1115243517Cutaneous melanoma--past, present, and future.J Am Acad Dermatol2004https://conductscience.org/library/papers/15243517PubMed
1216411049Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.Cancer Causes Control2006https://conductscience.org/library/papers/16411049PubMed
1316185266Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000.J Invest Dermatol2005https://conductscience.org/library/papers/16185266PubMed
1415519506Cutaneous malignant melanoma in Europe.Eur J Cancer2004https://conductscience.org/library/papers/15519506PubMed
1516222938Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control.Aust N Z J Public Health2005https://conductscience.org/library/papers/16222938PubMed
163408978Experience of a public education programme on early detection of cutaneous malignant melanoma.BMJ1988https://conductscience.org/library/papers/3408978PubMed
171348807Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.Lancet1992https://conductscience.org/library/papers/1348807PubMed
187804992Public education projects in skin cancer. Experience of the Canadian Dermatology Association.Cancer1995https://conductscience.org/library/papers/7804992PubMed
1915787817Predictions of skin cancer incidence in the Netherlands up to 2015.Br J Dermatol2005https://conductscience.org/library/papers/15787817PubMed
2012640685Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.Int J Cancer2003https://conductscience.org/library/papers/12640685PubMed

See all 24 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.

PMIDTitleJournalYearIn PapersSource
41061011Melanoma in Peru: 1000 patients and 10 years of experience.PLoS One2025https://conductscience.org/library/papers/41061011PubMed
39816394Prevalence and clinicopathological characteristics of de novo metastatic cancer at a major radiotherapy centre in West Africa: a cross-sectional study.Ecancermedicalscience2024https://conductscience.org/library/papers/39816394PubMed
36569825
An immune risk score predicts progression-free survival of melanoma patients in South China receiving anti-PD-1 inhibitor therapy-a retrospective cohort study examining 66 circulating immune cell subsets.
Front Immunol2022https://conductscience.org/library/papers/36569825PubMed
35353115Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.JAMA Dermatol2022https://conductscience.org/library/papers/35353115PubMed
34557790Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981-2018.Lancet Reg Health Eur2021https://conductscience.org/library/papers/34557790PubMed
33863315Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.BMC Cancer2021https://conductscience.org/library/papers/33863315PubMed
33671417Melanoma Prevention: Comparison of Different Screening Methods for the Selection of a High Risk Population.Int J Environ Res Public Health2021https://conductscience.org/library/papers/33671417PubMed
32380816Primary amelanotic melanoma of the mandibular gingiva.Arch Craniofac Surg2020https://conductscience.org/library/papers/32380816PubMed
32000743
Sun protection education for adolescents: a feasibility study of a wait-list controlled trial of an intervention involving a presentation, action planning, and SMS messages and using objective measurement of sun exposure.
BMC Public Health2020https://conductscience.org/library/papers/32000743PubMed
30106842Stage-specific incidence trends of melanoma in an English region, 1996-2015: longitudinal analyses of population-based data.Melanoma Res2020https://conductscience.org/library/papers/30106842PubMed
28587543Clinical and prognostic factors in 98 patients with malignant melanoma in China.J Int Med Res2017https://conductscience.org/library/papers/28587543PubMed
27408455Primary Gingival Melanoma: An Important Entity.J Maxillofac Oral Surg2016https://conductscience.org/library/papers/27408455PubMed
27073541Sun exposure and melanoma prognostic factors.Oncol Lett2016https://conductscience.org/library/papers/27073541PubMed
26151043Esculetin, a Coumarin Derivative, Exhibits Anti-proliferative and Pro-apoptotic Activity in G361 Human Malignant Melanoma.J Cancer Prev2015https://conductscience.org/library/papers/26151043PubMed
25592837Melanoma characteristics in Brazil: demographics, treatment, and survival analysis.BMC Res Notes2015https://conductscience.org/library/papers/25592837PubMed
25330295More people die from thin melanomas (⩽1 mm) than from thick melanomas (>4 mm) in Queensland, Australia.J Invest Dermatol2015https://conductscience.org/library/papers/25330295PubMed
23915380A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world.BMC Cancer2013https://conductscience.org/library/papers/23915380PubMed
23589817Incidence of childhood and adolescent melanoma in the United States: 1973-2009.Pediatrics2013https://conductscience.org/library/papers/23589817PubMed
22363864Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.ISRN Dermatol2012https://conductscience.org/library/papers/22363864PubMed
21867531A questionnaire to measure melanoma risk, knowledge and protective behaviour: assessing content validity in a convenience sample of Scots and Australians.BMC Med Res Methodol2011https://conductscience.org/library/papers/21867531PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17533392

GET https://conductscience.org/api/papers/v1/17533392/references?page=2